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Saturated and monounsaturated fatty acids are the 
most abundant fatty acid species in mammalian organ­
isms, and their distribution is regulated by stearoyl-CoA 
desaturase, the enzyme that converts saturated into mo­
nounsaturated fatty acids. A positive correlation be­
tween high monounsaturated fatty acid levels and neo­
plastic transformation has been reported, but little is 
still known about the regulation of stearoyl-CoA desatu­
rase in cell proliferation and apoptosis, as well as in 
cancer development. Here we report that simian virus 
40-transformed human lung fibroblasts bearing a knock­
down of human stearoyl-CoA desaturase by stable anti­
sense cDNA transfection (hSCDas cells) showed a con­
siderable reduction in monounsaturated fatty acids, 
cholesterol, and phospholipid synthesis, compared with 
empty vector transfected-simian virus 40 cell line (con­
trol cells). hSCDas cells also exhibited high cellular lev­
els of saturated free fatty acids and triacylglycerol. In­
terestingly, stearoyl-CoA desaturase-depleted cells 
exhibited a dramatic decrease in proliferation rate and 
abolition of anchorage-independent growth. Prolonged 
exposure to exogenous oleic acid did not reverse either 
the slower proliferation or loss of anchorage-indepen­
dent growth of hSCDas cells, suggesting that endoge­
nous synthesis of monounsaturated fatty acids is es­
sential for rapid cell replication and invasiveness, two 
hallmarks of neoplastic transformation. Moreover, 
apoptosis was increased in hSCDas cells in a ceramide- 
independent manner. Finally, stearoyl-CoA desaturase- 
deficient cells were more sensitive to palmitic acid- 
induced apoptosis compared with control cells. Our 
data suggest that, by globally regulating lipid metabo­
lism, stearoyl-CoA desaturase activity modulates cell 
proliferation and survival and emphasize the important 
role of endogenously synthesized monounsaturated 
fatty acids in sustaining the neoplastic phenotype of 
transformed cells.
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Saturated (SFA)1 and monounsaturated (MUFA) fatty acids 
are the most abundant fatty acids present in mammalian or­
ganisms. As building blocks of phospholipids, triacylglycerols 
(TAGs), and cholesteryl esters (CEs), fatty acids are fundamen­
tal constituents of membranes, vital stores of metabolic energy, 
and relevant mediators/signals that regulate major cellular 
activities. Because changing levels of SFA and MUFA can 
influence a broad spectrum of cellular functions, the content 
and distribution of SFA and MUFA within the cell must be 
tightly controlled. One key regulator of fatty acid composition 
is stearoyl-CoA desaturase (SCD), the endoplasmic reticulum­
resident enzyme that catalyzes the introduction of the first 
double bond in the cis-Nd position of several saturated fatty 
acyl-CoAs, principally palmitoyl-CoA and stearoyl-CoA, to 
render palmitoleyl- and oleyl-CoA (1).
The presence of SCD has been described in a wide variety of 
organisms (2). Among the best studied mammalian models, 
rodents have four SCD isoforms (SCD 1-4) expressed in a tis­
sue-specific manner (3). SCD expression and activity are reg­
ulated by a large number of factors, including dietary choles­
terol and fatty acids, several hormones, and growth factors (4). 
Most of these studies have been done using rodent models, and 
little is known about human SCD. Two isoforms of SCD (SCD 
and ACOD4) have been described for humans, both exhibiting 
—85% homology with murine SCD1 (5, 6). ACOD4 is almost 
exclusively expressed in fetal brain, with little or no detectable 
expression in adult tissues (6). The SCD gene is ubiquitously 
expressed, although the overall level of expression differs 
among tissues, with high levels in brain, liver, heart, and 
lung (5).
Because the lipid products of SCD are used for modulating 
membrane structure (7, 8) and/or energy metabolism (3), SCD 
has been suggested to play a key role in cell proliferation and in 
lipid-mediated cytotoxicity. In this regard, it has been observed 
that SCD is a target of growth factors and hormones that 
regulate key cell cycle events. Retinoic acid and transforming 
growth factor-/! are reported to regulate SCD expression in a 
number of untransformed human cell types (9, 10). Very re­
cently, it was demonstrated that platelet-derived growth factor 
and fibroblast growth factors FGF-2 and FGF-4 up-regulate 
SCD expression in human fibroblasts through the activation of 
sterol regulatory element-binding protein 1 (SREBP-1) by 
phosphatidylinositol 3-kinase (11). In this work, the activation 
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1 The abbreviations used are: SFA, saturated fatty acid; MUFA, 
monounsaturated fatty acids; SCD, stearoyl-CoA desaturase; TAG,: 
triacylglycerol; CE, cholesterol ester; FFA, unesterified fatty acid; 
hSCD, human stearoyl-CoA desaturase; FBS, fetal bovine serum; BSA, 
bovine serum albumin; MEM, minimal essential medium.
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synthesis of phospholipids and cholesterol, supporting the idea 
that MUFA synthesis is an integral part of the program of 
membrane synthesis. SCD has a role in lipid-mediated apopto­
sis, because it has been shown that overexpression of SCD1 in 
Chinese hamster ovary cells protects against the cytotoxic ef­
fects of excess SFA (12).
A linkage between SCD activity and tumor cell proliferation 
has also been proposed. Increased expression level of SCD was 
found in colonic and esophageal carcinoma and in hepatocellu­
lar adenoma (13), as well as in chemically induced tumors (14). 
In addition, we recently reported that SV40-transformed hu­
man lung fibroblasts (SV40-WI38 cells) show a —5-fold higher 
fatty acid synthesis and a —3-fold increased protein and activ­
ity levels of SCD with respect to their parental normal WI38 
cell line, and this results in an increased MUFA/SFA ratio and 
a more fluid cell membrane environment (15). Because SV40- 
WI38 cells display enhanced phospholipid synthesis together 
with a fast replication rate (16), the increased synthesis of 
MUFA in these cells may satisfy the high demand for this fatty 
acid species for membrane lipid synthesis.
We hypothesize that SCD, by modulating the relative levels 
of SFA and MUFA, is a primary regulator of essential events of 
lipid homeostasis, such as membrane lipid synthesis and re­
modeling as well as buffering signaling and/or toxic fatty acids. 
As such, low SCD activity would lead to reduced proliferation 
and/or increased cell death. To test this hypothesis, we de­
signed a model of reduced SCD gene expression in human cells. 
To this end, we employed SV40-transformed human lung fibro­
blasts, because this cell line bears several biological and bio­
chemical features that make these cells an advantageous model 
to test the effects of SCD deficiency in lipid homeostasis as well 
as in cell proliferation, carcinogenesis, and programmed cell 
death as follows: (i) SCD protein and activity levels are signif­
icantly up-regulated by SV40-transformation, leading to a high 
MUFA synthesis and content (15); (ii) As a human cell strain, 
SV40-WI38 cells contains the main SCD isoenzyme present in 
human cells, if not the only active isoform (5, 6, 17), which may 
increase the understanding of SCD functions in cell physiology; 
(iii) Also, these human cells possess the advantage of a well 
known mechanism for transformation based on the inactiva­
tion of p53 and Rb activities, a condition that is present in the 
most frequent human cancers (18, 19).
In the present study, we show that the stable knockdown 
of SCD gene expression by a cDNA antisense strategy in hu­
man neoplastic SV40-WI38 cells decreases both MUFA and 
phospholipid synthesis and promotes the accumulation of 
SFA-enriched unesterified fatty acids (FFAs) and TAG. Con­
comitantly, SCD deficiency leads to a slower rate of cell prolif­
eration, a loss of anchorage-independent growth, and higher 
rate of ceramide-independent apoptosis. Furthermore, cells 
that express only low levels of SCD are more sensitive to the 
cytotoxic effects of exogenous palmitic acid. Because the biolog­
ical phenotype of SCD-deficient cells was not reversed by the 
addition of exogenous oleic acid, endogenously synthesized 
MUFA must be essential lipid molecules to maintain cellular 
lipid homeostasis. We take this to suggest that SCD action is 
important in the physiology of proliferating cells, even in con­
ditions of normal supply of MUFA.
EXPERIMENTAL PROCEDURES
Materials—SV40-transformed human lung fibroblasts (SV40-WI38) 
were obtained from the American Type Culture Collection (Manassas, 
VA). Tire human SCD cDNA fragment, corresponding to bp 278-2005 of 
the sequence (GenBank™, accession no. AF097514) was a kind gift of 
Dr. Stephen M. Prouty, R. W. Johnson Research Institute, PA, and Dr. 
William Samuel, National Institutes of Health. Lipofectamine™, 
pcDNA3 plasmid, Geneticin™, cell culture media, and other culture 
reagents were from Invitrogen. Ultrafiltered fetal bovine serum (FBS) 
was from Gensa (Buenos Aires, Argentina). Cell culture supplies were 
from Greiner BioOne (Frickenhausen, Germany). Restriction enzymes 
and other molecular biology reagents were from Promega (Madison, 
WI). [1-14C] Stearic acid and [2-3H] glycerol were from American Radio- 
labeled Chemicals, Inc. (St. Lotus, MO). [l-14C]Acetic acid, [l-14C]oleic 
acid, [meiAyZ-14C]choline chloride, Iy-32P|ATP, and [6-3H] thymidine 
were from Amersham Biosciences. Fatty acid-free bovine serum albu­
min (BSA), mouse anti-/3-actin monoclonal antibody, anti-mouse IgG 
peroxidase conjugate, protease inhibitors mixture, and etoposide were 
purchased from Sigma. Pure lipid standards were from Doosan Serdary 
(Yongin, Korea). Silica gel 60 chromatography plates were from Merck 
(Darmstadt, Germany). Analytical-grade solvents were from Carlo Erba 
(Milano, Italy). Hoechst 33258 was purchased from Aldrich, and 
CaspACE™ Assay System was from Promega. Escherichia coli diacyl­
glycerol kinase was purchased from Calbiochem-EMD Biosciences (San 
Diego, CA).
Cell Culture—SV40-WI38 cells as well as the derived transfected cell 
lines were routinely cultured in bicarbonate buffered minim inn essen­
tial medium with Earle’s salts (MEM) supplemented with 10% heat- 
inactivated FBS, penicillin (100 units/ml), streptomycin (10 pg/ml), 1% 
non-essential amino acids, and 1% MEM vitamin solution (growing 
medium), at 37 °C, 5% CO2, and 100% humidity.
Stable SCD Knockdown in SV40-trans formed Cells—The human 
SCD cDNA fragment was subcloned into a pcDNA3 vector in an anti­
sense orientation into EcoRI and Hindlll restriction sites. The 
construct pcDNA3-hSCDas (for “human Stearoyl-CoA Desaturase 
antisense” cDNA) was transfected into SV40-WI38 cells using Lipo­
fectamine™ reagent according to the manufacturer’s instructions. Pos­
itively transfected cells were selected with 600 gg/ml Geneticin™ in 
culture medium for 14 days. Several individual cell colonies (hSCDas) 
were then isolated using cloning cylinders. Empty pcDNA3 vector was 
stably transfected into SV40-WI38 cells, and these cells were consid­
ered the control cell line.
Immunoblotting—Western blot analysis was performed as previously 
described (15). Polyclonal rabbit anti-SCD (1:500 dilution) or monoclonal 
mouse anti-/3-actin (1:10000 dilution) were used as primary antibodies.
Lipid Extraction—Cell monolayers were washed twice with ice-cold 
PBS and scraped from the Petri dishes with two additions of 1 ml of 
ice-cold methanol. 1 ml of chloroform and 0.5 ml of distilled water were 
added to complete the extraction as described by Bligh and Dyer (20).
Determination of SCD Activity—Preconfluent hSCDas and control 
cells were incubated with trace amounts (2.3 p,M) of [14C] stearic acid 
(0.25 gCi/dish) in culture medium containing 0.5% BSA for 6 h. At the 
end of the incubation, total cell lipids were extracted as described. Total 
cellular lipids were saponified, and released fatty acids were then 
esterified with boron trifluoride in methanol for 3 h at 64 °C. The 
derivated methyl esters were separated by argentation TLC following 
the procedure of Wilson and Sargent (21), using a solvent phase con­
sisting of hexane:ethyl ether (90:10, by vol). Pure stearic acid and oleic 
acid standards were run in parallel to the samples. Fatty acid spots on 
TLC were detected by radiometric scanning as well as by lipid staining 
with iodine vapors. Spots were scraped from the TLC plate and quan­
tified with a scintillation counter. Tire level of [14C]oleic acid produced 
was calculated from specific activity of [14C|stearic acid and normalized 
to cellular protein content.
Metabolic Labeling—Preconfluent cells were incubated for up to 24 h 
either with 0.25 gCi/dish [14C]oleic acid (2.1 gM), 0.5 gCi/dish [14C]ac- 
etate (4.2 gM), or 0.25 gCi/dish [14C]stearic acid (2.3 p,M), in 10% FBS 
MEM media supplemented with 0.5% BSA. At the end of each labeling 
period, the radioactive medium was recovered, and cell monolayers 
were washed twice with 0.1% BSA in ice-cold PBS, to eliminate residual 
label on the cell surface. Lipid extraction was carried out as described.
Lipid Quantification and Analysis—Analysis of mass and radioactiv­
ity of neutral and polar lipids species were carried out as described by 
Bagnato and Igal (16). Briefly, neutral and polar lipids species were 
separated on silica gel 60 TLC plates using one-dimensional single 
development procedures. Neutral lipid separation was carried out with 
hexane:ethylether:acetic acid, 80:20:2 (by vol) as solvent system. Polar 
lipid species were resolved in a solvent system consisting of chloroform: 
methanol:ammonium hydroxide:water, 50:37.5:3.5:2 (by vol). Pure lipid 
standards were seeded and run on the TLC plates in parallel to sam­
ples. For the 14C labeling experiments, individual lipid spots detected 
by radiometric scanning were scraped into plastic vials, and radioac­
tivity levels were determined in a liquid scintillation counter. The 
amount of 14C tracer incorporated in each lipid class was calculated 
from the specific activity of each substrate and normalized to cellular 
protein content.
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lipids species were resolved by TLC as stated above and scraped from 
chromatoplates, and fatty acid methyl esters from each lipid were 
obtained as described above. Methyl esters of fatty acids were analyzed 
by gas chromatography in a Hewlett Packard HP6890 GC apparatus, 
fitted with a flame ionization detector, and equipped with an Omega- 
Wax 250 capillary column. Chromatographic peaks were identified by 
comparison of their retention times with those of pure fatty acid stand­
ards, and percent distribution was calculated. Quantification of TAG 
and FFA mass was performed using 20 gg of heptadecanoic acid as an 
internal standard.
Cell Prolifera tion—To determine the growth rate of control and hSC­
Das cell lines, 1.6 X 105 cells were seeded in triplicate 60-mm Petri 
dishes. Twenty-four hours later, medium was replaced with fresh me­
dium. Medium was then changed every 2 days. At different times up to 
144 h, cells were trypsinized and counted in a hemocytometer. At all 
time points, cell viability was determined by trypan blue exclusion.
PHJThymidine Incorporation into Cell DNA—The rate of DNA syn­
thesis of both hSCDas and control cells was analyzed by determining 
the levels of [3H]thymidine-labeled DNA as described by Bagnato and 
Igal (16). In some experiments, both groups of cells were incubated with 
100 gM oleate for 72 h before the incubation with [3H]thymidine.
Colony Formation Assay—Control and hSCDas cells were plated at 
1 X 104 cells per 60-mm dishes in quadruplicate in MEM containing 
10%' FBS, in the presence or absence of 200 gM oleate and 0.3%' (w/v) 
agar plated onto a bottom layer of 0.6%' (w/v) agar in MEM. After 4 
weeks, the presence or absence of multicellular colonies (more than 
eight cells) in both cell groups was observed under the microscope. For 
macroscopic visualization, cell colonies were stained with ethidium 
bromide in PBS for 2 h, and photographed under UV light.
Apoptosis Analysis I: Fragmentation of PHJThymidine-labeled 
DNA—The determination of DNA fragmentation was performed essen­
tially as described by Venable et al. (22). DNA samples from preconflu­
ent hSCDas cells and control cells were labeled with 0.4 /.¿Ci of [3H] thy­
midine in regular growing medium for 24 h. Medium was removed, the 
cell monolayers were washed twice with PBS at 37 °C, and cells were 
incubated in serum-free medium with or without different concentra­
tions of palmitic acid and/or oleic acid complexed to BSA (fatty acid/BSA 
ratio 2:1 or 5:1) for 24 h. Next, the chase medium containing detached 
apoptotic cells was collected, and the [3H] radioactivity was determined 
in a scintillation counter. Cell monolayers were lysed in PBS with 1%' 
Triton X-100 and 0.2 /.¿M EDTA, collected, and sedimented by centrifu­
gation at 14,000 rpm for 15 min. Radioactivity was quantified in the 
supernatant, containing fragmented [3H]DNA, and in the pellet con­
taining the intact cellular DNA, which was washed and resuspended in 
1%' Triton X-100 and 0.2 /.¿M EDTA. The percentage of fragmented DNA 
was estimated according to the following calculation: (chase medium 
disintegrations/min (dpm) plus supernatant dpm (/total dpm.
Apoptosis Analysis II: Detection of Nuclear FragmentationlConden- 
sation by Fluorescence Microscopy—The presence of nuclear condensa­
tion or fragmentation during apoptosis was examined by Hoescht 33258 
staining and fluorescence microscopy following the procedure described 
by Kasai et al. (23).
Apoptosis Analysis III: Determina tion of Caspase-3 Acti vi ty—Control 
and hSCDas cells were grown in 60-mm dishes until 80-90%' confluent. 
Cells were scraped from the dishes in ice-cold PBS and pelleted by 
centrifugation. Next, cells were resuspended in ice-cold 10 mM Tris-HCl 
buffer and disrupted by several cycles of freezing-thawing, followed by 
sonication in an ice-water bath. Caspase-3 activity was assayed in cell 
homogenates using a CaspACE™ Assay System (Promega) according 
the manufacturer’s instructions. Cells treated with 40 gM etoposide 
were used as positive control for apoptosis (15).
Apoptosis Analysis IV: Quantitation of Ceramide Levels—To deter­
mine the content of cellular ceramide, we performed a diacylglycerol 
kinase assay as described by Preiss et al. (24) and modified by Luberto 
and Hannun (25). Ceramide content was normalized to cellular 
protein content.
Determina tion of Cellular Protein—Total cellular protein content was 
measured as described by Lowry et al. (26), using BSA as a standard.
Sta tistical Analysis—All experiments were performed in triplicate or 
quadruplicate unless otherwise stated. Results are presented as 
means ± S.D. and statistical significance of the data were determined 
by Student’s t test or analysis of variance.
RESULTS
A Stable Reduction of SCD Levels Decreases the MUFA Con­
tent in Cell Lipids—We have previously reported that the on­
cogenic transformation of normal human fibroblast with SV40 
enhances the expression of SCD, leading to a significantly high 
MUFA/SFA ratio in cell membrane and a more fluid membrane 
environment (15). Unlike normal fibroblasts, SV40-trans- 
formed cells exhibit a neoplastic behavior in vitro, showing a 
fast replication rate and loss of anchorage independent-growth 
(16). In the present work, we examined whether SCD is rele­
vant for sustaining the biochemical and biological phenotype of 
transformed cells by generating SV40-transformed cells defi­
cient in SCD expression. For this purpose, several clones of 
SCD-ablated cells were isolated from a pool of SV40-trans- 
formed fibroblasts stably transfected with a fragment of human 
SCD cDNA in antisense orientation. Three clonal populations 
of antisense SCD cDNA-transfected cells, hSCDas-A, hSC- 
Das-C, and hSCDas-F, were chosen for experiments, because 
these clones exhibited the lowest SCD mRNA expression and 
enzyme activity. In these clones, SCD activity, measured by the 
conversion of exogenous [14C] stearic acid to oleic acid, was 
significantly reduced compared with mock-transfected cells, 
although to different extents (Fig. 1A). The hSCDas-A clone 
showed the lowest SCD activity (—70% decrease with respect to 
control cells), followed by hSCDas-C and hSCDas-F cells, in 
which SCD activity levels were reduced by 50 and 40%, respec­
tively, compared with control cells. As expected, the lower SCD 
activity was caused by a reduction of SCD protein level in the 
hSCDas cells; in our Western blot analysis of the SCD-ablated 
clone hSCDas-A, the content of SCD enzyme was decreased 
when compared with control levels (Fig. IB). These observa­
tions indicate that the stable transfection of antisense SCD 
cDNA into SV40-transformed cells led to a depletion of SCD 
protein and a concomitant loss in A9-desaturating activity. 
Because the hSCDas-A clonal line exhibited the lowest SCD 
activity, this cell line was selected for performing most of the 
experiments carried out in the present work.
To determine whether the decrease in SCD activity was 
effectively translated into a significant change in cellular fatty 
acid composition, the fatty acid profile of phospholipids was 
analyzed (Table LA). As expected, MUFA species were signifi­
cantly diminished in hSCDas-A cells as compared with the 
controls. Palmitoleic acid (16:lii-7) was reduced by 56%, 
whereas oleic acid (18: lii-9) and cis-vaccenic acid (18:lii-7) 
decreased by 14 and 23%, respectively. Stearic acid (18:0) levels 
increased by 43% in the SCD-deficient cell line with respect to 
mock-transfected cells. However, total palmitic acid levels were 
not different between the knockdown and control cells. Overall, 
the MUFA/SFA ratio, which indirectly expresses the rate of 
A9-desaturation, was reduced by 32% in the hSCDas-A line 
when compared with controls. Similarly, the ratio of MUFA/ 
SFA in total lipids extracted from the hSCDas-C clone was 
reduced by 19% with respect to controls (data not shown). This 
indicates that the decrease in SCD activity is paralleled by an 
equivalent reduction in the MUFA/SFA ratio of cellular lipids. 
When the fatty acid profile of the main polar lipid species, 
phosphatidylcholine and phosphatidylethanol amine, was an­
alyzed the changes in SFA and MUFA were similar to those 
seen in total phospholipids of the SCD-deficient hSCDas-A cell 
line (Table I, B and C).
SCD-deficient Cells Segregate SFA away From Phospholip­
ids and into Neutral Lipids—It has been shown that SCD 
activity is mainly linked to neutral lipid metabolism in rodents 
(27, 28). However, recently published data suggest that SCD 
activation in normal and neoplastic human fibroblasts is asso­
ciated with membrane lipid synthesis (11, 15). To elucidate the 
relationship between SCD and lipid synthesis in human cells, 
we investigated whether the incorporation of exogenous 
[14C] stearic acid into cellular lipids was altered in SCD-de- 
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Fig. 1. Determination of SCD activity and protein levels in hSCDas cells. For the determination of desaturase activity (A), controls and 
hSCDas cells (clones A-, C-, and F-) were grown to 80-90%' confluency and then incubated with [14C]stearic acid (0.25 gCi/dish) for 6 h in 10%' FBS, 
MEM. Conversion of [14C] stearic acid into oleic acid was measured following the separation of fatty acids on TLC plates impregnated with silver 
nitrate and determination of radioactivity. Values represent the mean ± S.D. of three samples. *,p < 0.01, by Student’s t test. For Western blot 
determinations (B), preconfluent cells from control and hSCDas-A groups were harvested and disrupted by sonication on ice. Proteins were resolved 
by SDS-PAGE, and the presence of SCD and /3-actin was detected by Western blot and quantitated by densitometric analysis. SCD levels were 
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and the mock-transfected controls were incubated with 
[14C]stearic acid for 6 h, and levels of the major radiolabeled 
lipids were determined (Fig. 2A) As expected, most of the ex­
ogenous 14C-fatty acid (—90%) was incorporated into the phos­
pholipid fraction, with the remaining 14C label incorporated 
into TAG and CE. In addition, the 14C-fatty acid-labeled CE 
and PL fractions remained virtually unchanged between both 
SCD-deficient and control cell lines. On the other hand, we 
observed a 93% higher incorporation of the 14C-fatty acid into 
TAG in SCDas-A cells compared with control cells (Fig. 2A). 
Increases of 55 and 53% in TAG labeling inhSCDas-C and 
hSCDas-F cells, respectively, with respect to controls were also 
detected (data not shown). We take these latter observations to 
indicate that the level of TAG formation from exogenous 
[14C] stearic acid is inversely correlated to the degree of SCD 
deficiency.
The differences in the labeling of 14C-lipid between hSCDas 
and control cells may be a consequence of the unequal levels of 
[14C] stearic acid and its desaturated product oleic acid result­
ing from SCD-deficiency, hence we incubated the cells with 
exogenous [14C] oleic acid for 6 h and analyzed the levels of 
14C-labeled lipids. As shown in Fig. 2B, the incorporation of 
oleic acid was 20% higher into total phospholipids of hSCDas 
cells compared with empty vector-transfected cells. Interest­
ingly, [14C] oleate-labeled TAG and CE fractions decreased by 
—35% in hSCDas cells, indicating a differential acylation pat­
tern for saturated and unsaturated fatty acids in SCD-deficient 
cells, with a preferential utilization of oleic acid for the forma­
tion of phospholipids.
Depletion of SCD Leads to a Decrease in de Novo Synthesis of 
Phospholipids and Neutral Lipids—Because the incorporation 
of exogenously added 14C-fatty acid into both polar and neutral 
lipid fractions was differentially affected in hSCDas cells, we 
next examined the de novo synthesis of phospholipids and the 
major neutral lipids using [14C]acetate as tracer. After incu­
bating the cells with the tracer for 24 h, the levels of different 
14C-labeled lipids were analyzed. The synthesis of 14C-phos- 
pholipids and [14C] cholesterol was reduced by 40% and 33%, 
respectively, in SCD-deficient cells compared with control cells 
(Fig. 3, A and B). In addition, [14C]acetate labeling of FFA,
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Table I
Distribution of fatty acids in phospholipids from control
and hSCDas-A cells
Fatty acids from total cellular phospholipids (A), phosphatidylcholine 
(B), and phosphatidylethanolamine (C) were converted into methyl 
ester derivatives and analyzed by capillary GC. Part A shows percent 
distribution of total phospholipids; parts B and C show fatty acid 
desaturation indexes in phosphatidylcholine and phosphatidylethanol­
amine, respectively. Values express the mean ± S.D. of three samples.
“p < 0.001, by Student’s t test. 
b p < 0.01, by Student’s t test.
“ X, unidentified fatty acid.
Fatty acid Control hSCDas -A
%
A)
16:0 23.51 ± 0.59 24.45 ± 2.18
16:ln-7 4.77 ± 0.20 2.10 ± 0.17“
18:0 13.21 ± 1.18 19.00 ± 1.236
18:ln-9 38.02 ± 0.63 32.88 ± 0.78“
18:ln-7 11.25 ± 0.05 8.69 ± 0.20“
18:2n-6 4.38 ± 0.05 6.62 ± 0.15“
X“ 2.03 ± 0.08 2.46 ± 0.42
20:4n-6 2.84 ± 0.07 3.80 ± 0.226
16:1/16:0 0.20 ± 0.01 0.09 ± 0.001“
16:1 + 18:ln-7/16:0 0.68 ± 0.01 0.44 ± 0.04“
18:ln-9/18:0 2.90 ± 0.28 1.74 ± 0.116
MUFA/SFA 1.47 ± 0.06 1.01 ± 0.04“
B)
16:1/16:0 0.17 ± 0.03 0.10 ± 0.01“
16:1 + 18:ln-7/16:0 0.41 ± 0.09 0.27 ± 0.016
18:ln-9/18:0 3.62 ± 0.50 1.77 ± 0.19“
MUFA/SFA 0.98 ± 0.16 0.67 ± 0.03“
C)
16:1/16:0 0.23 ± 0.07 0.09 ± 0.03''
16:1 + 18:ln-7/16:0 0.48 ± 0.03 0.24 ± 0.05“
18:ln-9/18:0 1.71 ± 0.09 0.82 ± 0.16“
MUFA/SFA 0.99 ± 0.03 0.53 ± 0.07“
TAG, and CE fractions was decreased by 50%, 40%, and 48%, 
respectively, in hSCDas cells relative to mock-transfected cells 
(Fig. 30. These results were further confirmed by analyzing 
the formation of phospholipids and triacylglycerol using [3H]g- 
lycerol as a tracer of the glycerolipid backbone. The incorpora­
tion of [3H] glycerol into both phospholipids and triacylglycerol 
were significantly decreased in hSCDas-A cells (data not 
shown). Further studies using [14C] choline as a marker indi­
cated that the synthesis of the main membrane phospholipid in 
mammalian cells, phosphatidylcholine, was substantially de­
creased in the hSCDas-A cells (data not shown).
Accumulation of TAG and FFA in SCD-deficient Cells—Pub­
lished reports have suggested that excess TAG content may be 
deleterious for survival of cardiac and pancreas /3-cells (29, 30). 
On the other hand, it also has been proposed that TAG accu­
mulation protects cells from toxic FFA by segregating these 
lipids away from apoptotic pathways (31). Having observed 
that the SCD-deficient hSCDas cells exhibit a TAG pool that is 
highly labeled with [14C] stearic acid but also have a diminished 
TAG formation when traced with [14C] acetate, we determined 
whether SCD-deficient cells had indeed altered their TAG 
mass in response to the observed changes in de novo lipid 
synthesis and fatty acid turnover. To assess this, we quantified 
the cellular TAG mass in both control and hSCDas-A cells. As 
shown in Fig. 4A, TAG content increased by 46% in the SCD- 
deficient cells with respect to controls. Interestingly, when the 
acyl composition of the TAG was analyzed, a —40% increase in 
the content of both palmitic and stearic acids was observed 
(Fig. 4A, right panels). The amount of MUFA in TAG remained 
unchanged (data not shown). These results clearly indicate 
that, despite low de novo synthesis, the TAG pool expanded at 
the expense of using fatty acids, mainly SFA, likely generated 
by a greater phospholipid turnover.
Excess levels of FFA, mainly the saturated forms, within the 
cells have been proposed to induce cell death by both ceramide­
dependent and -independent mechanisms (29, 32). However, 
the intracellular content and molecular species of FFA were not 
measured in these published studies. Hence, we asked whether 
the FFA mass and composition were altered in the hSCDas-A 
cell line relative to their controls. Stably transfected SCD- 
deficient cells showed a 2-fold higher FFA content compared 
with the corresponding mock-transfected cell line (Fig. 4B). 
Concomitantly, unesterified palmitic and stearic acid levels 
were 2- and 2.3-fold increased (Fig. 4B, right panels'), indicating 
that the expansion of the FFA pool was due to the increase in 
the SFA fraction. Accumulation of FFA in SCD-deficient cells 
was further confirmed in cells incubated with [14C] stearic acid 
for 6 h; 14C-labeled-FFA increased by —65% in hSCDas-A when 
compared with controls (Fig. 5A). This expansion of the FFA 
pool seems to be specific for SFA, because no change in 
[14C]FFA labeling was observed following the incubation of 
hSCDas-A and control cells with [14C] oleic acid for 6 h 
(Fig. 5B).
Reduced Expression of SCD Slows the Rate of Cell Proliferation 
and Abolishes the Anchorage-independent Growth in SV40-trans- 
formed Cells—Given our observations that diminished SCD ex­
pression lowers MUFA levels in phospholipids, as well as the rate 
of synthesis of membrane phospholipids and cholesterol, we ad­
dressed the question as to whether cell growth would be compro­
mised by these alterations in lipid metabolism. First, we esti­
mated the rate of DNA synthesis in three SCD-deficient clones 
and control cells by measuring [3H] thymidine incorporation into 
total cellular DNA. As shown in Fig. 6A, all hSCDas cell clones 
had a significantly reduced synthesis of DNA when compared 
with the control cells. Remarkably, hSCDas-A cells, which had 
the lowest SCD activity, showed the most profound reduction in 
[3H]DNA formation (62% lower than controls) and the greatest 
effect on reducing cell proliferation. For hSCDas-C and -F cell 
clones, which held greater levels of SCD expression, [3H]DNA 
synthesis diminished by 49 and 47%, respectively, compared with 
control cells. Interestingly, the addition of 100 /am oleic acid to the 
growth medium for to 72 h did not change [3H]thymidine incor­
poration into DNA of hSCDas cells (Fig. 6B), suggesting that an 
endogenous pool of oleic acid is required for sustaining a high 
DNA synthetic rate. Additionally, growth curves for hSCDas-A 
cells and the mock-transfected cells were determined (Fig. 60. 
The empty vector-transfected SV40 cells displayed the most 
rapid growth rate; this rate of growth was comparable to the 
neoplastic growth pattern of non-transfected cells (16). In sharp 
contrast, the SCD-deficient cells grew at a significantly slower 
rate, showing increasing differences with the control cells at 
longer incubation times.
Because SCD deficiency dramatically decreased the prolifer­
ation rate of this neoplastic SV40-transformed cell line, we 
tested if other alterations in the transformed phenotype were 
taking place in hSCDas cells. Anchorage-independent growth 
is a typical feature of neoplastic cell transformation, hence we 
proceeded to analyze the ability of control and hSCDas-A cells 
to form colonies on a soft agar surface, in presence or absence 
of 200 /am oleic acid. Cells were seeded on agar and grown for up 
to 4 weeks to allow the formation of multicellular colonies. As 
shown in Fig. 60, mock-transfected cells gave rise to numerous 
colonies, whereas hSCDas-A cells failed to produce multicellu­
lar colonies, indicating that SCD-deficiency completely sup­
pressed anchorage-independent proliferation of the SV40- 
transformed cells. Interestingly, oleate treatment did not 
reverse the incapacity of hSCDas-A cells to form multicellular 
colonies, indicating that endogenously synthesized MUFA are 
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Fig. 2. [14C]Stearic acid incorporates preferentially into TAG, whereas exogenous [14C]oleic acid is selectively incorporated into 
phospholipids of SCD-deficient cells. hSCDas-A and empty-vector transfected control cells were grown until 80-90% confluent. Cells were 
incubated with either [14C]stearic acid or [14C]oleic acid for 6 h, and cell lipids were extracted and separated by TLC. Lipid spots were scraped, and 
their radioactivity was quantified by scintillation counting. PL, total phospholipids; TAG, triacylglycerols; CE, cholesterol esters. A, [14C] stearic 
acid-labeled lipids; B, [14C]oleic acid-labeled lipids. Values express the means ± S.D. of three determinations. *, p < 0.01, by Student’s t test.
A B
C
Fig. 3. The de novo synthesis of neutral and polar lipids is decreased in SCD-depleted cells. Preconfluent control and hSCDas-A cells 
were incubated with [14C]acetate (0.50 gCi/dish) for 24 h. Phospholipids (A), cholesterol (B), unesterified fatty acids IFFA), triacylglycerols (TAG'), 
and cholesterylesters (CE) (C) were resolved on TLC plates, and the radioactivity levels were measured by scintillation counting. Values represent 
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SCD Deficiency Promotes Apoptosis in a Ceramide-independ­
ent Manner and Enhances Palmitic Acid-mediated Cytotoxicity— 
Excess SFAs in serum are suggested to promote apoptosis. 
Several mechanisms have been proposed to be responsible for 
this lipotoxic phenomenon, including excess ceramide synthe­
sis (29), alterations in mitochondrial membranes (33), and ex­
acerbated generation of reactive oxygen species (12). Most of 
the studies that investigate the lipotoxic effects of SFA on cell 
viability were performed with short term exposures to cytotoxic 
concentrations of these fatty acids. Hence, the question of 
whether SCD acts to reduce the cytotoxicity of increased levels 
of SFA either derived from exogenous or endogenous sources is 
still not fully understood. To this end, we tested the hypothesis 
that the reduction of SCD expression would induce apoptosis by 
promoting SFA accumulation. The degree of fragmentation of 
[3H] thymidine-labeled DNA was analyzed as a marker for pro­
grammed cell death in hSCDas-A cells and control cells. As 
displayed in Fig. 7A, the percentage of apoptosis in SCD-defi- 
cient cells was —70% higher than in control cells. The greater 
rate of apoptosis in hSCDas cells was confirmed by the pres­
ence of fragmented/condensed nuclei by fluorescence micros­
copy after staining with Hoescht fluorophore (Supplemental 
Fig. S1A). In addition, caspase-3 activity was measured in both 
cell groups using etoposide-treated cells as positive controls. As 
shown in Fig. 7B, hSCDas-A cells showed a 4-fold increase in 
caspase activity compared with mock-transfected cells, further 
corroborating the positive correlation between SCD depletion 
and programmed cell death.
















Fig. 4. High levels of TAG and FFA 
in SCD-deficient SV40-cells. Total lip­
ids from preconfluent control and hSC- 
Das-A cells were extracted and TAG and 
FFA were resolved by TLC. Mass and 
fatty acid composition of both lipid frac­
tions were determined by gas chromatog­
raphy. A, triacylglycerol mass (TAG), in­
sets: 16:0 (upper); 18:0 (lower). B, 
unesterified fatty acids (FFA), insets: 16:0 
(upper), 18:0 (lower). Values represent the 
mean ± S.D. of triplicate samples. *,p < 
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Pig. 5. Stearic acid, but not oleic 
acid, increases in the FFA fraction of 
SCD-deficient cells. Preconfluent con­
trol and hSCDas-A cells were labeled with 
either [14C]stearic acid or [14C]oleic acid 
for 6 h, total lipids were extracted, and 
FFA fractions were resolved by TLC. 
Spots corresponding to unesterified 
[14C]stearic acid (A) and unesterified 
[14C]oleic acid IB) were scraped into vials, 
and radioactivity was measured. Data 
represent the mean ± S.D. of three deter­
minations. *,p < 0.01, by Student’s t test.
The role of ceramide in the induction of apoptosis has been 
firmly established, but the relationship of ceramide levels and 
lipid accumulation is still unclear. It has been observed that 
accumulation of long chain SFA, which are substrates in de 
novo ceramide synthesis, leads to cell death in pancreatic 
/3-cells (29). However, in other cell types, SFA-mediated apo­
ptosis seems to occur in a ceramide-independent manner (32). 
Thus, we tested the hypothesis that the excess of largely sat­
urated FFA and TAG caused by the decrease in SCD expression 
alter intracellular ceramide levels. Ceramide content was 
measured in hSCDas-A and control cells cultured under regu­
lar growth conditions. We observed that the levels of this lipid 
mediator were not significantly different between both types of 
cells (Fig. 7C). Taken as a whole, the results of these experi­
ments support a role for SCD in cell survival. Moreover, the 
events of programmed cell death promoted by SCD deficiency 
are not mediated through a ceramide-dependent mechanism.
Previous studies have indicated that high levels of exogenous 
SFA promote apoptosis, whereas the addition of oleic acid or 
overexpression of rat SCD1 prevents the SFA-induced cell 
death (12). In an attempt to extend this observation, we incu­
bated hSCDas-A and control cells with different concentrations
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A B
Fig. 6. SCD gene knockdown slows 
proliferation rate and suppresses the 
anchorage-independent growth of 
SV40-transformed cells. A, near conflu­
ent control cells and hSCDas-A, -C, and F- 
clones were pulsed with [3H] thymidine 
(1/xCi/dish) in MEM with 10% FBS for 2 h 
at 37 °C, and total [3H]DNA was quanti­
fied. Values represent the mean ± S.D. of 
triplicate samples. B, control and hSC- 
Das-A cells were incubated with 100 p,M 
oleate in 10% FBS MEM for 72 h. At the 
end of the treatment, cells were pulsed 
with 1 p,Ci/dish of [3H] thymidine for 2 h, 
and formation of total cell [3H]DNA was 
estimated. Values correspond to the 
mean ± S.D. of four determinations. Val­
ues bearing different letters are signifi­
cantly different at p < 0.01 (analysis of 
variance). C, control and hSCDas-A cells 
were seeded in 60-mm Petri dishes and 
grown in MEM with 10% FBS. Cells were 
trypsinized and counted at time points up 
to 144 h. Data correspond to triplicate 
dishes. Some error bars are hidden by 
symbols. *, p < 0.01, by Student’s t test. 
b, 1 x 105 hSCDas-A and controls cells 
were seeded in MEM containing 10% 
FBS, and 0.3% agar, with or without 200 
p,M oleate, over a layer of 0.6% agar. After 
4 weeks, cells colonies were stained with 
ethidium bromide and photographed un­
der UV light. A single cell culture dish, 
representative of four independent exper­
iments, is shown for each cell strain and 
treatment.
C
of palmitic acid for 24 h and determined the rate of apoptosis by 
analyzing the degree of [3H] thymidine-labeled DNA fragmen­
tation. To avoid the influence of serum fatty acids, these stud­
ies were carried out in FBS-depleted medium. To ensure a high 
unbound FFA concentration in the incubation medium, we 
used a 5:1 fatty acid:BSA ratio. As shown in Fig. ID, untreated 
hSCDas cells exhibited a 72% higher degree of DNA fragmen­
tation than control cells. Palmitic acid supplementation signif­
icantly increased apoptosis in a dose-dependent manner in both 
cell groups. In mock-transfected cells, treatments with 250 and 
500 /am palmitic acid increased the cell death rate by 1.8- and 
2.7-fold, respectively, compared with untreated control cells. 
Interestingly, SCD deficiency made the cells more susceptible 
to the cytotoxic action of palmitic acid. At 250 and 500 /am 
palmitic acid, the percentage of apoptotic hSCDas-A cells in­
creased by —2.5- and —4.5-fold, respectively, with respect to 
untreated SCD-deficient cells. To test the protective effect of 
MUFA on SFA-induced apoptosis, control and hSCDas-A cells 
were co-treated with 500 /am palmitic acid and 250 /am oleic 
acid, and the level of apoptosis was determined. Interestingly, 
co-supplementation with 250 /am oleic acid reduced apoptosis in 
both 500 /am palmitate-treated hSCDas and control cells to 
levels observed in conditions of no treatment for each cell 
group. Additionally, groups of both cell lines received 250 and 
750 /am oleate alone, showing no changes with respect to their 
non-treated cell counterparts. However, oleic acid treatment 
did not reverse the higher basal apoptosis rate seen in hSC- 
Das-A cells.
In experiments resembling more physiological conditions 
(low unbound FFA, achieved by a ratio fatty acid:BSA of <2), 
neither 250 nor 500 /am palmitate supplement increased apo­
ptosis over the rate seen in cells without fatty acid treatment 






BSA ratios, 100 /am palmitic acid, a concentration almost sim­
ilar to that found in human serum (34), did not trigger cell 
death beyond basal levels in either control or SCD-deficient cell 
strains (data not shown).
DISCUSSION
In our studies, the stable transfection of SV40-transformed 
cells with antisense human SCD cDNA led to a significant 
decrease in the expression and, consequently, the activity of 
SCD. This was accompanied by a substantial reduction in the 
MUFA/SFA ratio of the major membrane phospholipids, PC 
and PE, and in TAG and FFA fractions. The different grade of 
SCD deficiency in independent hSCDas clones was mirrored by 
a proportionate decay in MUFA levels, indicating that SCD is 
the main regulator of MUFA content in SV40-transformed 
cells. Moreover, the relevance of SCD in controlling the relative 
abundance of SFA and MUFA is further supported by the 
observation that the alterations in MUFA levels in SCD-defi­
cient cells persisted even in the presence of significant amounts 
of MUFA (—200 /am) present in the FBS-supplemented growth 
media.
In addition to the profound alterations in fatty acid distribu­
tion in the main phospholipid fractions promoted by SCD 
knockdown, the overall synthesis of phospholipids was signifi­
cantly reduced in the SCD-deficient cell lines. This provides 
evidence that SCD may play a role not only in the regulation of 
fatty acid remodeling of pre-existing membrane lipids but also 
in the de novo synthesis of phospholipids in the fast replicating 
SV40-transformed cells. Because a drastic reduction in endog­
enous fatty acid synthesis occurred in SCD-ablated cells, the 
diminished phospholipid synthesis may be produced by a de­
crease in de novo synthesized glycerolipid substrates. In addi­
tion, SCD seems to play a central role in the control of the
D
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Fig. 7. hSCDas cells exhibit a greater rate of apoptosis and are more sensitive to palmitic acid-mediated cytotoxicity. The rate of 
programmed cell death in control and hSCDas-A cells, incubated in MEM with 10%' FBS in presence of 40 gM etoposide or vehicle, was determined 
by estimating the fragmentation index of [3H]thymidine-labeled DNA (A). Caspase-3 activity was quantified in homogenates from preconfluent 
hSCDas-A and control cells treated with 40 gM etoposide or vehicle IB). Ceramide content was measured in total lipids extracted from controls and 
hSCDas-A cells grown to near confluence (C). The rate of apoptosis was determined by the analysis of DNA fragmentation in control and hSCDas-A 
cells incubated in MEM without FBS in the presence of palmitic acid (Pal, 250 gM or 500 gM), oleic acid (Ole, 250 gM or 750 gM), or both for 24 h 
(D). Data represent the mean ± S.D. of three or four determinations. *, p < 0.05, compared with control cells; #, p < 0.05 compared with same cell 






. jbc.org by guest on O
ctober 3. 2019
synthesis of membrane lipids, because SCD knockdown led to a 
down-regulation in the synthesis of cholesterol, the other major 
structural lipid in cell membranes. In this context, it has been 
reported that the induction of cell replication with growth 
factors in human cells triggers a severalfold increase in expres­
sion of SCD, together with the activation of enzymes needed for 
cholesterol and phospholipid synthesis (11).
Under normal conditions, cellular phospholipid concentrations 
remain essentially constant, and therefore this lipid pool can 
accommodate a limited amount of fatty acids. Thus, excess con­
tent of a particular species of fatty acid in this pool may alter the 
composition and membrane properties of cellular membranes. 
Consequently, excess fatty acids must be channeled away into an 
expandable lipid pool like TAG. Indeed, we found that hSCDas 
cells showed a significant increase in the incorporation of 
[14C] stearic acid into FFA and TAG together with the expansion 
of the TAG and FFA pools. Both FFA and TAG were greatly 
enriched with SFA species, with no significant changes in MUFA 
levels. We take this to suggest that in a state of SCD deficiency, 
to preserve the membrane physical-chemical homeostasis, cells 
segregate excess SFA away from the phospholipid remodeling 
pool and store these fatty acid species under the form of TAG. 
This hypothesis is also supported by the observation that modi­
fications in the content and composition of the FFA fraction, a 
pool of intermediates for the formation of both phospholipids and 
TAG, occurs in a manner and degree similar to TAG. Exogenous 
[14C] oleate was excluded from TAG and FFA pools and segre­
gated preferentially into phospholipid fractions of SCD-deficient 
cells, further indicating a differential channeling of SFA and 
MUFA into the different lipid species.
Our knockdown of SCD promoted dramatic effects on cell 
proliferation. The growth rate for hSCDas cells was signifi­
cantly decreased leading to a doubling time that was —70% 
slower than that of mock-transfected cells and approximately 
similar to normal parental WI38 fibroblasts (16). It is notewor­
thy that the magnitude of growth inhibition was strongly cor­
related to the degree of SCD depletion in the three clones of 
SCD-deficient cells. This firmly establishes a direct relation­
ship between A9-desaturation and cell replication. Because 
SV40-WI38 cells exhibit neoplastic behavior, the effect of SCD 
knockdown on their rapid proliferation rate may be an indica­
tion of a reversion of the neoplastic cell phenotype. This is 
supported by the observation that SCD depletion in SV40-WI38 
cells also suppresses anchorage-independent growth, another 
hallmark of malignant transformation. These data indicate 
that the high cellular SCD activity is responsible, at least
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Fig. 8. Hypothetical model for the 
regulation of cell proliferation and 
apoptosis by SCD in SV40-trans- 
formed cells. In empty-vector trans­
fected SV40-cells (A, control cells), onco­
genic transformation activates a global 
program for the formation of new mem­
brane lipids that includes a high rate de 
novo synthesis and A9-desaturation of 
fatty acids and greater production of 
phospholipids and cholesterol. MUFA are 
preferentially channeled toward the phos­
pholipid fraction to create a more fluid 
physical-chemical membrane environ­
ment that favors an active cell replica­
tion. Ablation of SCD expression and ac­
tivity in the transformed cells (B, h SC Das 
cells) leads to lower levels of MUFA and 
accumulation of SFA in membrane phos­
pholipids. The synthesis of phospholipids 
and cholesterol is impaired by SCD defi­
ciency, causing a reduction in the cell pro­
liferation rate. In addition, excess content 
of SFA inhibits fatty acid synthesis and 
accumulates as FFA and TAG, two events 




partially, for the abnormal cell proliferation and invasiveness 
capacity of SV40-transformed cells.
At this point, we cannot explain how a reduction in SCD 
expression affects the molecular mechanisms of cell prolifera­
tion and invasiveness in SV40-transformed cells. Some of the 
alterations in the growth properties of SCD-deficient cells are 
likely to be caused by the down-regulation of either phospho­
lipid and/or cholesterol synthesis needed to maintain a rapid 
rate of membrane formation. Alternatively, changes in the 
MUFA/SFA ratio of phospholipids may alter the physical­
chemical properties of cell membranes, and this may account 
for the observed effects. Phospholipid synthesis is required for 
normal cell cycle progression (35), whereas deficient formation 
of phosphatidylcholine stops cell growth and promotes apopto­
sis (36). Impaired phospholipid synthesis leads to a loss in cell 
growth and invasiveness in human neoplastic cells (16, 37) and 
mouse lymphoma cells (38). In addition, the proportional en­
richment of phospholipids with SFA promotes cytostatic effects 
in cancer cells (39). Furthermore, sterculic acid, an inhibitor of 
SCD activity, exhibits an anti-proliferative action in neoplastic 
cells likely by increasing the relative abundance of SFAs (40). 
Finally, the inhibition of fatty acid synthesis observed in SCD- 
depleted cells may be also responsible for the decrease in cell 
proliferation. In many cancer cells the active de novo fatty acid 
synthesis appears essential for sustaining a rapid cell growth, 
whereas inactivation of fatty acid synthase by means of phar­
macological inhibitors reduces cell proliferation and triggers 
programmed cell death (41).
It is also tempting to speculate that, by regulating SCD 
activity and, consequently, the MUFA/SFA ratio of phospholip­
ids, cells may be able to modulate the structural properties of 
cellular membranes by altering the organization of lipid do­
mains which may, in turn, influence signaling receptor func­
tions that favor neoplastic cell features like fast proliferation, 
adhesion and invasion. In this regard, SCD activity is known to 
regulate the activity of proteins that are resident in the plasma 
membrane and inner cellular membranes (7, 8). Furthermore, 
changes in oleic acid abundance are known to produce impor­
tant effects on signal transduction networks related to cell 
proliferation and death, like phosphatidylinositol 3-kinase (42) 
and protein kinase C (43).
Our experiments provide the first clear evidence that SCD is 
regulating programmed cell death and add valuable informa­
tion to previous studies that suggest a role for SCD in protect­
ing mammalian cells against SFA-mediated lipotoxicity. Inter­
estingly, SCD-deficient cells undergo apoptosis even in regular 
growing conditions, strongly indicating that SCD activity is 
crucial for cell survival. The relevance of the anti-apoptotic role 
of SCD is twofold. First, SCD activity is required to avoid the 
cytotoxic effect of SFA overload. SCD-depleted cells were more 
sensitive to SFA-induced lipotoxicity, supporting previous 
studies that indicated that SCDl-overexpressing Chinese ham­
ster ovary cells are highly resistant to palmitate-induced apo­
ptosis (12). The observation that, unlike Chinese hamster 
ovary cells, SFA-mediated apoptosis was triggered in SV40- 
cells only at a high SFA:BSA ratio, suggests that sensitivity to 
SFA-induced cytotoxicity likely depends on cell type and specie. 
Second, the alterations in FFA and TAG composition and mass 
observed in the SCD-deficient cells are likely to contribute to 
the process of programmed cell death. Accumulation of TAG in 
non-adipose cells triggers the apoptosis program by providing 
high levels of SFA substrates for the de novo synthesis of 
ceramide (30). Although excess contents of FFA and TAG were 
found in this study, the observations that ceramide levels were 
unaltered in hSCDas-A cells rules out the involvement of a 
ceramide-dependent mechanism of programmed cell death 
caused by SCD ablation.
To summarize the current results and our previous data (15), 
we have shown that neoplastic SV40 transformation imposes a 
constitutive activation of MUFA synthetic machinery by trig­
gering a series of events that increases the fatty acid synthesis 
and SCD activity with a consequent enrichment of membrane 
phospholipids with MUFA (Fig. 8A). MUFA production is an 
essential component for the adequate synthesis of membrane 
lipids, because transformed cells show a parallel activation of 
the formation of the main structural membrane lipids, phos­
pholipids, and cholesterol (this work and Ref. 15). Moreover, 
highly fluid cell membranes are required for neoplastic cells 
to establish appropriate structural and metabolic conditions to 
sustain high rates of proliferation and invasion and to 
avoid apoptosis.
In addition, we provide evidence indicating that SCD is, 
indeed, essential for maintaining the biochemical and biologi­
cal phenotype of neoplastic transformation. SCD deficiency 
generated by ablating SCD expression in SV40 cells leads to a 
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ducing a more rigid cellular membrane (Fig. SB). As a result of 
the diminished provision of endogenously synthesized MUFA, 
the incorporation of exogenous oleic acid into phospholipids of 
hSCDus cells is enhanced, but this cannot compensate for the 
more saturated fatty acid profile of membrane lipids and its 
consequences. The block in SCD expression also reduces the 
synthesis of phospholipids, especially phosphatidylcholine, and 
cholesterol. These changes in the content and quality of mem­
brane lipids may lead to alterations in cell proliferation and 
invasiveness, as observed in the hSCDas clones. Additionally, 
SFA accumulates and consequently inhibits de novo fatty acid 
synthesis, but FFA and TAG pools are expanded because of the 
preferential channeling of SFA into these lipid fractions. Due to 
the highly saturated nature of both FFA and TAG, these lipids 
may display increased cytotoxic effects in the transformed cells, 
thereby triggering apoptosis.
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